Carboplatin Injection 150mg

About Carboplatin Injection 150mg

Carboplatin Injection 150mg Uses

• Ovarian cancer, including first line and recurrent disease
• Non small cell lung cancer
• Small cell lung cancer
• Head and neck cancer
• Bladder cancer
• Endometrial cancer
• Testicular cancer as part of combination chemotherapy regimens

Carboplatin Injection 150mg Benefits

• Lower risk of kidney and nerve damage compared to older platinum chemotherapy drugs
• Dose can be calculated using kidney function, allowing safer individualized treatment
• Works well when combined with paclitaxel, etoposide or other chemotherapy agents
• Can often be given as an outpatient infusion in a hospital oncology unit

What Experts Say

Oncologists usually calculate the Carboplatin dose using the Calvert formula rather than body surface area alone. This formula links the target area under the curve, known as AUC, to the patient's kidney function measured through glomerular filtration rate. This approach allows the dose to be adjusted for each patient rather than following one fixed milligram amount.

Blood counts are checked closely during treatment because bone marrow suppression is the main dose limiting effect of this drug. Platelet counts often reach their lowest point around three weeks after a dose, so cycles are usually spaced three to four weeks apart to allow recovery. A drop in white blood cells or platelets before the next cycle may call for a delay or a dose adjustment.

Cancer specialists weigh overall disease burden, prior treatment history and how well a patient tolerated earlier cycles before deciding whether to continue at the same dose or adjust it. Chemotherapy plans are reviewed regularly through blood tests and imaging so treatment stays matched to how the disease is responding.

Drug Class

• Platinum based antineoplastic agent
• Works as an alkylating like compound that damages cancer cell DNA
• Classified as a cell cycle non specific chemotherapy drug

Carboplatin Injection 150mg formula

• Carboplatin

Available forms

• Injection

How to use Carboplatin Injection 150mg?

• This injection is given only in a hospital or cancer care setting by a doctor or trained oncology nurse
• The infusion is administered slowly into a vein, usually over 15 to 60 minutes
• Each dose is calculated individually using body weight, kidney function and target AUC before every cycle
• A typical cycle repeats once every 3 to 4 weeks
• Blood tests are checked before each dose to confirm it is safe to proceed
• Close monitoring continues during and shortly after the infusion for any reaction

Drug Interactions

• Aminoglycoside Antibiotics: Drugs such as gentamicin combined with Carboplatin raise the risk of kidney and hearing damage.
• Other Bone Marrow Suppressing Drugs: Using other chemotherapy agents together increases the risk of severe low blood counts.
• Radiotherapy: Radiation therapy given at the same time can add to bone marrow suppression.
• Live Vaccines: Should be avoided during treatment since a weakened immune system raises infection risk from the vaccine itself.
• Blood Thinners: Combined use with low platelet counts from Carboplatin raises the risk of bleeding.
• Phenytoin: Platinum chemotherapy can lower phenytoin blood levels, so levels should be monitored in patients with epilepsy.
• Other Nephrotoxic Drugs: Medicines such as amphotericin B can add to kidney strain when combined with Carboplatin.

Risks and warnings

• Bone Marrow Suppression: Carboplatin can lower white cells, red cells and platelets, with low platelet count often the dose limiting effect, so blood counts are checked before every cycle.
• Hypersensitivity Reactions: Allergic reactions including anaphylaxis can occur and the risk increases with repeated cycles, so patients are watched closely from the second cycle onward.
• Kidney Function: This drug carries less kidney risk than older platinum chemotherapy, but creatinine clearance is still checked regularly since dosing depends on it.
• Pregnancy: This medicine can harm an unborn baby and is not recommended during pregnancy, so effective contraception is advised during and after treatment.
• Breastfeeding: Not recommended while receiving this medicine due to possible harm to a nursing infant.
• Hearing Changes: Some patients notice hearing changes or ringing in the ears, particularly with repeated cycles, so hearing checks may be advised.
• Vaccinations: Live vaccines should be avoided during treatment since the weakened immune response can raise infection risk.
• Secondary Cancers: Long term platinum chemotherapy use carries a small later risk of a second cancer.
• Injection Site Care: Leakage of the drug outside the vein can irritate nearby tissue, so the infusion site is watched throughout.

Carboplatin Injection 150mg Side Effects

• Low white blood cell count and higher infection risk
• Low platelet count with easy bruising or bleeding
• Low red blood cell count and tiredness
• Nausea and vomiting
• Loss of appetite
• Fatigue and general weakness
• Numbness or tingling in the hands or feet
• Hearing changes or ringing in the ears
• Mild hair thinning
• Changes in taste
• Low magnesium, potassium or sodium levels
• Mild rise in liver enzymes
• Allergic reactions ranging from skin rash to severe anaphylaxis
• Changes in kidney function in some patients

Storage Conditions

• Store the vial in a refrigerator between 2 and 8 degrees Celsius
• Keep the vial in its original carton to protect it from light
• Do not freeze the vial
• Storage stays within the hospital or oncology pharmacy cold chain, not for home use
• Once prepared for infusion, use within the time specified by the hospital pharmacy and discard any unused solution
• Keep out of reach of children and dispose of as hazardous chemotherapy waste